Advertisement

Agents and Actions

, Volume 23, Issue 3–4, pp 204–206 | Cite as

Effects of β-endorphin on rat mast cells

  • A. Sydbom
Mast Cells and Neuropeptides

Abstract

The endogenous opioid peptide β-endorphin induced a dose-dependent release of histamine from rat peritoneal mast cells. The threshold concentration was around 10−6M and the optimal concentration of 2×10−5M released 35% of the total histamine. The release of histamine was very rapid, complete within 10 s, and very similar to that induced by neurotensin or compound 40/80. The histamine release was temperature dependent and inhibited at increased extracellular calcium concentrations. Taken together, the findings indicate that the release of histamine induced by β-endorphin is a specific, energydependent process. The pattern of release has much in common with that induced by other basic peptides, such as neurotensin, dynorphin and substance P.

Keywords

Peptide Mast Cell Histamine Calcium Concentration Optimal Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    E. G. Fischer and N. E. Falke,β-Endorphin modulates immune functions, Psychother. Psychosom.42, 195–204 (1984).PubMedGoogle Scholar
  2. [2]
    A. I. Faden and J. W. Holaday,Experimental endotoxin shock: The pathophysiologic function of endorphins and treatment with opiate antagonists, J. infectious Dis.142, 229–238 (1980).Google Scholar
  3. [3]
    A. Sydbom and L. Terenius,The histamine-releasing effect of dynorphin and other peptides possessing Arg-Pro sequences, Agents and Actions16, 269–272 (1985).CrossRefPubMedGoogle Scholar
  4. [4]
    A. Sydbom and B. B. Fredholm,On the mechanism by which theophylline inhibits histamine release from rat mast cells, Acta Physiol. Scand.114, 243–251 (1982).PubMedGoogle Scholar
  5. [5]
    H. Imura and Y. Nakai,“Endorphins” in pituitary and other tissues, Ann. Rev. Physiol.43, 265–278 (1983).CrossRefGoogle Scholar
  6. [6]
    P. M. Mathews, C. J. Froelich, W. L. Sibbitt and A. D. Bankhurst,Enhancement of natural cytoxicity by β-endorphin J. Immunol.130, 1658–1662 (1983).PubMedGoogle Scholar
  7. [7]
    K. Nordlind and V. Mutt,Modulating effect of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate, Int. Archs. Allergy appl. Immun.81, 368–370 (1986).Google Scholar
  8. [8]
    H. W. McCain, I. R. Lamster and J. Bilotta,Modulation of human T-cell suppressor activity by beta endorphin and glycyl-l-glutamine, Int. J. Immunopharmac.8, 443–446 (1986).CrossRefGoogle Scholar
  9. [9]
    H. Shibata, M. Mio and K. Tasaka,Analysis of the mechanism of histamine release induced by substance P, Biochim. Biophys, Acta846, 1–7 (1985).Google Scholar

Copyright information

© Birkhäuser Verlag 1988

Authors and Affiliations

  • A. Sydbom
    • 1
  1. 1.Department PharmacologyKarolinska InstitutetStockholmSweden

Personalised recommendations